XBiotech Inc.
NASDAQ: XBIT0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Sushma Shivaswamy
- Employees
- 92
- Headquarters
- Austin, United States
- IPO year
- 2015
- Market cap
- $71.3M
- Website
- https://www.xbiotech.com
Loading XBIT…
Loading profile data…Frequently asked questions about XBIT
What does XBiotech Inc. (XBIT) do?
XBiotech Inc. is a biopharmaceutical firm specializing in the discovery, development, and commercialization of True Human monoclonal antibodies. Their primary focus involves building a robust pipeline of product candidates aimed at combating both inflammatory and infectious diseases. Furthermore, the company is advancing interleukin-1 alpha-base...
Where does XBIT trade?
XBiotech Inc. (XBIT) trades on the NASDAQ Global Select.
What sector is XBIT in?
XBiotech Inc. (XBIT) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of XBiotech Inc.?
Sushma Shivaswamy is the chief executive officer of XBiotech Inc. (XBIT).
Where is XBiotech Inc. headquartered?
XBiotech Inc. is headquartered in United States.
Does XBIT pay a dividend?
XBiotech Inc. (XBIT) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did XBIT go public?
XBiotech Inc. (XBIT) completed its initial public offering in 2015.